Heron Therapeutics (HRTX) Net Cash Flow Growth (3y) (2013 - 2026)
Heron Therapeutics (HRTX) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
NCF Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
89.97% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-13.44% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
33.37% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Heron Therapeutics |
76.81 Mn |
46.84 Mn |
24.07 Mn |
-30.37% |
| Date | Value |
|---|
| Mar 31, 2026 |
-30.37% |
| Dec 31, 2025 |
25.64% |
| Sep 30, 2025 |
143.95% |
| Jun 30, 2025 |
30.78% |
| Mar 31, 2025 |
42.08% |
| Dec 31, 2024 |
26.01% |
| Sep 30, 2024 |
30.70% |
| Jun 30, 2024 |
-26.32% |
| Mar 31, 2024 |
43.41% |
| Dec 31, 2023 |
-37.83% |
| Sep 30, 2023 |
14.08% |
| Jun 30, 2023 |
15.46% |
| Mar 31, 2023 |
-27.98% |
| Dec 31, 2022 |
-70.71% |
| Sep 30, 2022 |
-36.28% |
| Jun 30, 2022 |
-31.63% |
| Mar 31, 2022 |
-58.95% |
| Dec 31, 2021 |
-46.18% |
| Sep 30, 2021 |
46.38% |
| Jun 30, 2021 |
-14.78% |
